Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Moretti

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Science Translational Medicine|January 22, 2025
Perinatal dysfunction of innate immunity in cystic fibrosisFlorian Jaudas, Florian Bartenschlager, Bachuki Shashikadze, et al.
Journal of Clinical Medicine|July 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY StudyPaolo Gallo, Antonio De Vincentis, Francesca Terracciani, et al.
Circulation|October 25, 2021
Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart SyndromeMarkus Krane, Martina Dreßen, Gianluca Santamaria, et al.
Nature Cell Biology|May 13, 2022
Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitorsChristine M Poch, Kylie S Foo, Maria Teresa De Angelis, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldFrancesca Terracciani, Antonio De Vincentis, Daphne D'Amato, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Science Translational Medicine|January 22, 2025
Perinatal dysfunction of innate immunity in cystic fibrosisFlorian Jaudas, Florian Bartenschlager, Bachuki Shashikadze, et al.
Journal of Clinical Medicine|July 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY StudyPaolo Gallo, Antonio De Vincentis, Francesca Terracciani, et al.
Circulation|October 25, 2021
Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart SyndromeMarkus Krane, Martina Dreßen, Gianluca Santamaria, et al.
Nature Cell Biology|May 13, 2022
Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitorsChristine M Poch, Kylie S Foo, Maria Teresa De Angelis, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldFrancesca Terracciani, Antonio De Vincentis, Daphne D'Amato, et al.
Pageof 10